Bill > HR1497

This bill replaces the existing National Institute of Allergy and Infectious Diseases (NIAID) with three separate national research institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill specifies that the directors of these new institutes will be appointed by the President and confirmed by the Senate for 5-year terms, with the possibility of one additional term. The bill details the specific purposes of each new institute: the National Institute of Allergic Diseases will focus solely on allergic diseases and disorders, the National Institute of Infectious Diseases will conduct research and support programs related to infectious diseases (including tropical diseases), and the National Institute of Immunologic Diseases will support research and programs concerning immunologic diseases and disorders. During the transition, the Director of the National Institutes of Health will oversee these new institutes until their individual directors are appointed. The bill also includes numerous technical amendments to update references in existing laws, ensuring that all current references to NIAID will be understood to refer to the appropriate new institute. The goal appears to be creating more focused and specialized research institutes to improve scientific understanding and potential treatments for allergic, infectious, and immunologic diseases.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/1497/all-info